Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.
Why I Won’t Pay a Penny Over $70 for Oil
by Robert Williams, Publisher
Wednesday, September 30, 2009
For the third consecutive month, The International Energy Agency (IEA) released an upward revision of its forecast for world oil demand. It juiced up August’s estimate by 500,000 barrels a day, citing better-than-expected economic growth in developing Asian economies and North America.
So this rejuvenated demand for oil will have a barrel trading north of $90 in the weeks ahead, right? (The current market price for a barrel of oil is about $72.)
Not so fast. Two factors will likely hold price down through the end of the year.
Factor #1: When the financial crisis hit, and oil demand waned, suppliers began storing the massive inventory excess on tankers. OPEC said that, “Some 60 million barrels of products, mainly middle distillates, are being held in floating storage, largely off Europe.” As our research indicates, we’ve still got plenty to burn through.
Factor #2: The number of active oil rigs was cut by nearly half in the wake of Wall Street’s meltdown. But given the recent increase in demand, the global rig count – although modestly – is ticking upward again. Which means more oil will be coming out of the ground.
On news of the IEA’s revised forecast, Goldman Sachs said that it expects oil prices to reach $85 a barrel by the end of the year.
For the record, I’m a longer-term oil bull. But in the short term, Goldman is misreading the market.
Ahead of the Tape,
Robert Williams, Publisher
- With All the Cash Gone… Now What?
- Look Who Just Showed Up to the Takeover Party
- What to Make of the Rising “Fear Index”
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
In addition to once being a full-time trader of equities and equity derivatives, Robert Williams has also served as the lead financial analyst for a Forbes top-50 private corporation and an analyst for the endowment of a major academic institution.
Investment U RSS Feed